|« Previous month||Next month »|
21-Dec-2012 - in-Pharmatechnologist.com looks back at the biggest stories of 2012.
20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...
20-Dec-2012 - BASF says it will not extend its offer for pharmaceutical-grade omega-3 supplier Pronova BioPharma ASA beyond new mid-January deadline.
20-Dec-2012 - A new culture media collaboration with Sartorius Stedim Biotech (SSB) will boost capacity utilisation and add revenue says Lonza.
19-Dec-2012 - The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!
17-Dec-2012 - The ability to predict which non-stick coating is best suited to a particular tablet production environment will save drugmakers time and money according to I Holland.
13-Dec-2012 - BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3...
13-Dec-2012 - International Chemical Investors Group (ICIG) has bought Tessenderlo's underperforming European pharmaceutical intermediates and API business.
13-Dec-2012 - Representatives from Pfizer, J&J, Dow Corning and EMD Millipore will join IPEC Americas’ executive board and lead the excipient industry organisation as it moves to a new HQ.
13-Dec-2012 - Polypid says a new version of its lipid-polymer fusion-based technology has shown promise for the delivery of antibiotic in the treatment of bone fractures.
12-Dec-2012 - Merck Millipore hopes the promise of reducing the number of experiments needed during process development will win customers for its new MAb development kit.
12-Dec-2012 - Last week, BASF officially opened a pharmaceutical grade omega-3 active pharmaceutical ingredient (API) facility on the Isle of Lewis, Scotland that it gained with the acquisition of Equateq earlier this year ....
11-Dec-2012 - The MHRA says as many as 1,200 active pharmaceutical ingredient (API) manufacturing plants may need to be inspected to secure UK supply chains when new EU import laws come into effect...
11-Dec-2012 - A US advocacy group says Chinese crack down on counterfeiters is starting to work and that new Beijing unit will help.
10-Dec-2012 - Drugmaker Pfizer is on the list of 74 firms that have not paid their share of the $50m ‘backlog’ fee required under the Generic Drug User Fee Amendments (GDUFA ) law....
10-Dec-2012 - Showa Denko KK (SDK) wants a share of the of the biopharmaceutical resins sector and has partnered with purification tech firm BIA Separations (BIASep) to get it.
06-Dec-2012 - Pharmaceutical industry regulator Swissmedic says inclusion on EU third-country list illustrates the high quality of APIs made in the country.
06-Dec-2012 - Contract manufacturing organisation (CMO) AMRI has had its largest commercial supply contract renewed by GE Healthcare.
06-Dec-2012 - The US CDER wants drugmakers to find alternatives to two common plasticisers used in tablet coating after studies link them to developmental and reproductive defects in animals.
05-Dec-2012 - The GDUFA ‘self-identification’ requirement for generic API plants is not a flawed idea says SOCMA’s BDTF after FDA extends registration deadline citing fewer than expected registrations.
05-Dec-2012 - GE Healthcare says new cell science lab in Wales will save drugmakers time and money and create more accurate alternatives to animal-based drug toxicity testing models.
05-Dec-2012 - Sartorius Stedim Biotech has launched a new ‘fleece-like’ prefiltration technology that it says better protects expensive downstream systems.
05-Dec-2012 - Sunwin Stevia International has invested heavily in production capacity to support declared growth plans in China.
05-Dec-2012 - Criminals who steal drugs to try and resell them into the legitimate supply chain face longer sentences under new US legislation.
04-Dec-2012 - The EMA suggests that asking drugmakers to conduct risk assessments of manufacturing processes and supply chains could help prevent shortages.
04-Dec-2012 - Positron emission tomography (PET) drug manufacturers have three years to gain NDA or ANDA approval or they must remove their products from the market according to the US FDA.
03-Dec-2012 - The group whose comments on sponsor oversight drew criticism from ACRO says the industry group's preferred ‘trust and verify’ model only works if verification efforts are robust.
03-Dec-2012 - The USP says a new nomenclature scheme for salt drug substances will make for consistent product naming and ultimately help drugmakers.
03-Dec-2012 - Ranbaxy has predicted ‘market disruption’ after quality problems forced it to halt production of its generic version of Pfizer’s cholesterol buster Lipitor.
|« Previous month||Next month »|